(1)
Bangalee, A.; Hanley, S.; Bangalee, V. MEDICINE AND THE LAW: Dolutegravir As First-Line Antiretroviral Therapy in South Africa: Beware the One-Size-Fits-All Approach. S Afr Med J 2022, 112 (10), 787-790. https://doi.org/10.7196/SAMJ.2022.v112i10.16596.